Pain Medicine Doctors in Florida Medicare Details, Address, Contact

255 Pain Medicine doctors found. Showing 241 - 255

Jessica Anne Olsen, MD Pain Medicine - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 777 37th St Ste C103, Vero Beach, FL 32960 Phone: 772-971-6096    Fax: 949-561-4251

Majid Rafik Khalaf, MD Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1936 32nd Ave, Vero Beach, FL 32960 Phone: 772-778-8882    Fax: 772-778-8894

Dr. Humberto L Porrata, M.D. Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 2585 South State Road 7, Ste 110, Wellington, FL 33414 Phone: 561-795-8655    Fax: 561-795-3275

Dr. Roxanna Rasekhi, D.O. Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 2585 S State Road 7 Ste 110, Wellington, FL 33414 Phone: 561-795-8655

Dr. Keith J Dietrick, M.D. Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 2585 South State Road 7, Ste 110, Wellington, FL 33414 Phone: 561-795-8655    Fax: 561-795-3275

Dr. Howell R Goldfarb, M.D. Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 2585 South State Road 7, Ste 110, Wellington, FL 33414 Phone: 561-795-8655    Fax: 561-795-3275

Dr. Bruce I Hindin, D.O. Pain Medicine - Interventional Pain Medicine Medicare: Medicare Enrolled Practice Location: 2585 South State Road 7, Ste 110, Wellington, FL 33414 Phone: 561-795-8655    Fax: 561-795-3275

Dr. Maulik K Bhalani, MD Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 2553 Windguard Cir, Wesley Chapel, FL 33544 Phone: 813-388-2948    Fax: 813-388-6827

Rishi Das Gaiha, M.D. Pain Medicine - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 2700 Healing Way Ste 300, Wesley Chapel, FL 33543 Phone: 813-333-1186

Steven D Davis, L.AC. Pain Medicine - Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 27642 Cashford Cir, Wesley Chapel, FL 33544 Phone: 813-991-7877

James David Weinberg, MD Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 2590 Healing Way Ste 310, Wesley Chapel, FL 33543 Phone: 813-333-1186

Dr. Sheldon Regenbaum, MD Pain Medicine - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 N Dixie Hwy, Ste 103, West Palm Beach, FL 33401 Phone: 561-833-8893    Fax: 561-833-8939

Dr. Allan C Honculada, MD Pain Medicine - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 537 E Central Ave, Winter Haven, FL 33880 Phone: 863-294-9066    Fax: 863-293-7887

Lucien J. Parrillo, MD, MPH Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 325 1st St N, Winter Haven, FL 33881 Phone: 863-293-1191    Fax: 863-837-5334

Mohammad A Eldeeb, MD Pain Medicine - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 E Central Ave, Winter Haven, FL 33880 Phone: 863-293-1191

News Archive

Proteon Therapeutics commences PRT-201 Phase 1/2 clinical study in hemodialysis patients

Proteon Therapeutics, Inc., has initiated a Phase 1/2 human clinical study of its lead product, PRT-201, in end-stage renal disease (ESRD) patients undergoing surgery for arteriovenous graft (AVG) creation. The AVG study represents Proteon's second human clinical study in hemodialysis patients, previously announcing the initiation of a Phase 1/2 study of PRT-201 in ESRD patients undergoing surgery for arteriovenous fistula (AVF) creation earlier this year.

Anacor Pharmaceuticals files registration statement with U.S. SEC for initial public offering

Anacor Pharmaceuticals, Inc. today announced that it has filed a registration statement with the U.S. Securities and Exchange Commission ("SEC") relating to the proposed initial public offering of shares of its common stock. The number of shares to be offered and the price range for the offering have not yet been determined. All shares of the common stock to be sold in the offering will be offered by Anacor.

$20 billion in cardiovascular drug revenues soon subject to patent expiration

More than $20 billion in major cardiovascular drug revenues will be exposed to patent expiration in the next three to five years, according to a report by business intelligence firm Cutting Edge Information.

Children born to women on HIV therapy more likely to have microcephaly, developmental delays

Children born to women on HIV therapy containing the drug efavirenz were 2 to 2.5 times more likely to have microcephaly, or small head size, compared to children born to women on regimens of other antiretroviral drugs, according to an analysis funded by the National Institutes of Health.

Positive Phase 3 results from Tarsa's ORACAL study validates Unigene's oral peptide drug delivery technology

Unigene Laboratories, Inc. a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that the statistically significant top-line results released by its licensee, Tarsa Therapeutics, validate its proprietary oral peptide drug delivery technology.

Read more Medical News

› Verified 6 days ago

• «
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13(current)